Aurinia Pharmaceuticals (AUP) to Release Earnings on Thursday

Aurinia Pharmaceuticals (TSE:AUP) (NASDAQ:AUPH) will be announcing its earnings results after the market closes on Thursday, March 15th. Analysts expect the company to announce earnings of C($0.18) per share for the quarter.

Shares of Aurinia Pharmaceuticals (AUP) opened at C$6.90 on Thursday. The firm has a market capitalization of $572.39, a PE ratio of -4.06 and a beta of 3.34. Aurinia Pharmaceuticals has a 12-month low of C$5.68 and a 12-month high of C$14.17.

COPYRIGHT VIOLATION NOTICE: This report was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at

About Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company’s primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN.

Earnings History for Aurinia Pharmaceuticals (TSE:AUP)

Receive News & Ratings for Aurinia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurinia Pharmaceuticals and related companies with's FREE daily email newsletter.

Leave a Reply